Investigation of oxidant and antioxidant pathway changes in acute rheumatic fever

Abdurrahman Uner1, Ertan Sal, Murat Doğan

  • 1Department of Pediatric Cardiology, Medicine School of Yuzuncu Yil University, Van, Turkey.

Acta Cardiologica
|March 24, 2010
PubMed

Insights

Oxidative stress and reduced antioxidants contribute to tissue damage in acute rheumatic fever (ARF). Treatment normalized these markers, suggesting a role for oxidative stress in ARF pathogenesis.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Rheumatology

Background:

  • Acute rheumatic fever (ARF) is an inflammatory condition following streptococcal infection.
  • The precise mechanisms underlying ARF pathogenesis, particularly the role of oxidative stress, require further elucidation.

Purpose of the Study:

  • To investigate the involvement of oxidative stress in the clinical course and pathogenesis of acute rheumatic fever (ARF).

Main Methods:

  • The study involved 33 children diagnosed with ARF and 20 healthy controls.
  • Measurements included malondialdehyde (MDA) and reduced glutathione (GSH) as oxidative stress markers, alongside antioxidant vitamins (alpha-tocopherol, ascorbic acid, retinol, beta-carotene).
  • Levels were assessed before and after treatment in ARF patients.

Main Results:

  • Children with ARF exhibited significantly higher MDA and lower GSH levels compared to controls (P < 0.05, P < 0.001).
  • Post-treatment, MDA levels decreased and GSH levels increased significantly in ARF patients (P < 0.05, P < 0.01).
  • Antioxidant markers including alpha-tocopherol, retinol, and beta-carotene were significantly lower in ARF patients before treatment (P ≤ 0.05).

Conclusions:

  • Tissue damage in ARF is associated with increased oxidative stress and diminished antioxidant capacity.
  • These findings highlight the significant role of oxidative stress in ARF pathogenesis and suggest potential therapeutic targets.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...